FDA Drug Application (021345) for ARIXTRA by MYLAN IRELAND LTD

Back to FDA Applications sponsored by MYLAN IRELAND LTD

Application Number021345
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage2.5MG/0.5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameARIXTRA
Active IngredientFONDAPARINUX SODIUM

Active IngredientCount
List of drugs with Active Ingredient FONDAPARINUX SODIUM2


Back to FDA Applications sponsored by MYLAN IRELAND LTD